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Introduction: Obesity confers a survival advantage in the critically ill and in patients undergoing cardiac surgery.
We explored whether an obesogenic high fat diet could confer protection against post cardiopulmonary bypass
(CPB) acute kidney injury (AKI) in a swine model.
Methods: In this study, 28 anaesthetised adult female Landrace White swine (55 to 70 kg) were allocated into a
4 group design to either 2.5 hours of CPB or Sham operation with or without pre-procedural high fat (HF) feeding
containing 15% lard, 1.5% cholesterol and 1% cholic acid for 12-weeks (Groups: Sham, CPB, CPB + HF and Sham +
HF). Our primary endpoint was creatinine clearance measured at 1.5 and 24 hours post intervention. This is a
validated index of the glomerular filtration rate (GFR) in swine and an endpoint used in our clinical studies. Secondary
endpoints included measures of systemic and renal inflammation, endothelial homeostasis, tubular injury and
dysfunction, and inflammatory cell signalling. Differences between groups were calculated using analysis of
variance with adjustment for baseline differences for repeated measures.
Results: CPB in pigs fed a normal chow diet resulted in AKI. This was characterised by reductions in GFR
sustained for up to 24 hours post injury relative to Sham operated pigs fed a normal diet; mean difference
50.2 ml/min (95% CI 5.9 to 94.4). Post CPB AKI was also characterised by renal inflammation, parallel activation of
both pro-inflammatory (NF-kB, iNOS) and pro-survival pathways (pAkt, p70s6k, HIF-1α) and apoptosis. Pigs fed a
12-week high fat diet developed obesity and hyperlipidaemia. This was associated with increased redox sensitive
pro-inflammatory and anti-apoptotic signalling, and tubular epithelial cell proliferation. High fat feeding also
protected swine against post CPB AKI; mean difference in creatinine clearance CPB - CPB + HF −65.3 ml/min (95%
CI −106.9 to −23.7), by preserving endothelial homeostasis and function, and preventing the reductions in GFR,
loss of ATP and tubular apoptosis that characterise the extension phase of AKI in swine at 24 hours post injury.
Reno-protection was not attributed to pAkt signaling.
Conclusions: A high fat diet promoted obesity and renal inflammation and prevented post CPB AKI in swine.
This study provides insights into the obesity paradox and the failure of anti-inflammatory interventions to
improve clinical outcomes in patients at risk of post cardiac surgery AKI.* Correspondence: gjm19@le.ac.uk
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Acute kidney injury (AKI), defined clinically by an acute
reduction in glomerular filtration rate (GFR) and rises in
serum creatinine [1-3], complicates 25 to 30% of cardiac
surgery procedures, is associated with an in-hospital mor-
tality of 10%, and increases in-hospital resource use of up
to 100% [2-4]. Our understanding of the underlying pro-
cesses is poor and the prognosis for patients with AKI has
remained essentially unchanged for decades.
Recently, a number of epidemiological studies have re-
ported improved outcomes in critically ill patients who
are obese when compared with normal weight individ-
uals [5]. This phenomenon, termed the obesity paradox,
includes improved outcomes in intensive care patients
with acute kidney injury [6], as well as following cardiac
surgery [7,8]. A beneficial effect of obesity on inflamma-
tory organ injury is not universally accepted, however;
other authors have shown that very obese patients are at
increased risk of AKI following cardiac surgery [9].
There is also no clear mechanistic explanation, and the
findings of these studies have been variously attributed
to statistical bias [10], confounding and reverse epidemi-
ology [11], the anti-inflammatory effects of adipose tis-
sue [12,13], and the thrifty genotype [14].
We have described a novel large animal recovery model
of post-cardiopulmonary bypass (post-CPB) AKI in swine
[15] that shows quantitative and qualitative homology to
the renal injury and dysfunction observed in cardiac sur-
gery patients [16]. Renal inflammation, endothelial dys-
function and refractory cellular hypoxia are central
features of AKI in this model [17,18]. In a separate study
we noted significant adiposity in domestic swine fed an
atherogenic high-fat diet [19]. To investigate the mecha-
nisms underlying the obesity paradox we examined the ef-
fects of obesity caused by high-fat feeding on post-CPB
AKI in the swine recovery model using an index of GFR
as our primary outcome and measures of endothelial
homeostasis and inflammation as secondary outcomes.
Materials and methods
Twenty-eight female Large White Landrace crossbred pigs
approximately 4 months old and weighing 50 to 70 kg
were used. Animals received care in accordance with and
under license of the Animals (Scientific Procedures) Act
1986 and conforming with the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised
1996). The study had received local (University of Bristol)
institutional review board approval, and was conducted
under UK Home Office License PPL 30/2522.
Intervention
We allocated animals to four groups. Group 1 was sham
operation (surgical dissection with 2.5 hours of generalanaesthesia) in swine fed a 12-week normal chow diet
(n = 8; Sham). Group 2 was CPB (2.5 hours) in swine fed
a 12-week normal chow diet (n = 8; CPB). Group 3 was
sham operation in swine fed a 12-week high-fat diet
containing 15% lard, 1.5% cholesterol and 1% cholic acid
using a protocol we have previously shown to be athero-
genic [19] (n = 6; Sham +HF). Group 4 was CPB
(2.5 hours) in swine fed a 12-week high-fat diet for
12 weeks (n = 6; CPB + HF).
Anaesthesia and CPB were performed as described
previously [17,18]. Serum cholesterol levels were deter-
mined by measurement of plasma total cholesterol
from blood samples at 2, 4 and 12 weeks after com-
mencement of diet with an automatic analyser (East-
man Kodak Co., Rochester, NY, USA). After 12 weeks
of high-fat or normal chow diet, pigs were weighed and
anaesthetised with: induction anaesthesia, ketamine
(10 mg/kg, ketaset) and halothane (2.0 to 4.0%); and main-
tenance anaesthesia, halothane (1.0 to 2.0%) with nitrous
oxide 50% in oxygen. Depth of anaesthesia was assessed
by respiratory and pulse rates, ocular reflexes including
the palpebral response and ocular position. No muscle re-
laxant was administered. Animals were intubated and
positive-pressure ventilation was commenced in a circle
circuit using a Penlon Nuffield 200 (Abingdon, Oxford,
UK) initially to achieve peak inspiratory pressures of 30
cmH2O in a 1:4 (inspiratory:expiratory) ratio with modifi-
cations to maintain partial pressure of carbon dioxide be-
tween target values of 35 and 45 mmHg. Lung
compliance, partial pressure of oxygen (PaO2)/fraction of
inspired oxygen (FiO2) ratio, and work of breathing were
measured in vivo at baseline, 1.5 hours and 24 hours post
intervention using the SERVO-i Universal Ventilator
(Maquet Gmbh, Rastatt, Germany) and volume-controlled
ventilation with a tidal volume of 10 ml/kg, FiO2 of 0.5,
respiratory rate of 12 breaths/minute and peak end-
expiratory pressure of 5 cm/H2O.
Intravenous heparin (20,000 IU) and cefuroxime (750 mg)
were administered at the start of the experimental
period. The pre-intervention and post-intervention
period central venous pressure (8 to 12 mmHg), hydra-
tion, and sodium load (500 ml/hour, 0.9% normal
saline) were strictly controlled. Venous access and
measurement of central venous pressure was achieved
through direct puncture of the left external jugular vein
using a quad-lumen central venous catheter (Multi-
Cath4 Expert; Vygon GmbH, Aachen, Germany). Arter-
ial blood pressure was continuously monitored via a
20G Vygon catheter placed in the left common carotid
artery. Core body temperature was assessed using a rec-
tal temperature probe. Intramuscular buprenorphine
(vetergesic) was administered for pain relief. Cardiopul-
monary bypass was performed using a minimally inva-
sive approach. This avoided the need for a median
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ery. CPB venous drainage was established via a 24Fr
Smart Cannula® (Smartcanula LLC, Lausanne,
Switzerland) placed in the right external jugular vein
and advanced to the right atrium. Arterial return was
achieved via a 14Fr Smart Cannula® placed in the right
internal carotid artery and advanced to the brachioce-
phalic trunk. All animals received heparin 300 IU/kg.
The CPB circuit was primed with Hartman’s solution
(2,000 ml) and heparin (5,000 IU). Normothermic (38
to 39°C in pigs), nonpulsatile CPB was commenced by
a qualified clinical perfusionist using a Stöckert Multi-
flow Roller Pump (Sorin Group GmbH, Munich,
Germany) to achieve a target flow rate of 80 to 90 ml/
kg/minute of blood through the hollow fibre–mem-
brane oxygenator apparatus (Dideco D708 Compact-
Flo; Sorin Biomedica, Via Crescentio, Italy). Mean ar-
terial blood pressure was maintained between 65 and
75 mmHg with small incremental doses of the alpha-
adrenergic agonist metaraminol, FiO2 at 50% and par-
tial pressure of carbon dioxide between 35 and
45 mmHg. Total CPB (or sham intervention) time was
2.5 hours. This has been shown to result in significant
kidney injury in our previous work [17,18] and is rep-
resentative of a prolonged CPB duration, a recognised
risk factor for AKI in clinical studies [3]. Post-bypass
animals are recovered, then re-anaesthetised and out-
comes re-evaluated after 24 hours with nephrectomy
for tissue analyses performed prior to euthanasia.Table 1 Baseline data
Variable Sham Sha
(n = 8) (n
Weight (kg) 57.0 (1.4) 66
Serum creatinine (μmol/l) 138.8 (9.7) 136
Urine output (ml/kg/hour) 1.1 (0.17) 1.3
Creatinine clearance (ml/minute) 103.2 (8.2) 116
Creatinine clearance adjusted for body
weight (ml/minute/kg)
1.7 (0.2) 1.6
Serum total cholesterol (mmol/l) 1.5 (0.9) 15
Mean arterial blood pressure (mmHg) 81.1 (2.6) 73
Perioperative fluid administration (ml) 5,000 (4,750 to 5,000) 5,000 (5,0
Baseline haemoglobin (g/dl) 8.7 (0.4) 10
Perioperative metaraminol dosage (mg) 0 (0 to 0) 0 (
Baseline lung compliance (mmHg*l) 38.7 (1.6) 41
Baseline PaO2/FiO2 (mmHg) 464 (440 to 540) 412 (3
Work of breathing (J/l) 1.2 (0.05) 1.1
Data presented as mean (standard error of the mean) or median (interquartile rang
were as follows: Sham–Sham + HF, −9.2 kg (95% confidence interval (CI) = −17.2 to
HF, −15.9 kg (95% CI = −24.3 to −7.4), P <0.001; CPB–CPB + HF, −16.7 kg (95% CI = −
metaraminol dose were as follows: Sham–Sham + HF, 0.27 mg (95% CI = −10.4 to 10
Sham–CPB + HF, −14.1 (95% CI = −23.9 to −4.3), P = 0.006; CPB–CPB + HF, 2.3 mg (95
PaO2/FiO2, partial pressure of oxygen/fraction of inspired oxygen.Biochemical markers of renal injury
Creatinine clearance was calculated from urinary and
serum creatinine values and urinary volumes collected
over 90 minutes, at three time points: pre-intervention,
immediately post intervention and at 24 hours post
intervention, as described previously [17,18]. Serum and
urine creatinine values were determined with a commer-
cial reagent kit (HiCo Creatinine; Boehringer Mannheim
GmbH Diagnostica, Lewes, UK). Levels of inflammation
were determined by measurement of endothelin-1 (ET-1)
levels in renal tissue as described below, and the measure-
ment of urinary neutrophil gelatinase-associated lipocalcin
(NGAL; Bioporto Diagnostics A/S, Gentofte, Denmark)
and serum interleukin (IL)-6 (Invitrogen, Paisley, UK)
using enzyme-linked immunosorbent assay.
Endothelial function
To assess renal endothelial function at 24 hours, we mea-
sured in-vivo renal artery blood flow, and the response to
suprarenal intra-aortic acetylcholine (endothelial-dependent
response) or sodium nitroprusside (endothelial-independ-
ent response) infusion. Renal blood flow was measured
directly by placing a transonic perivascular flowprobe
(Oxford Optronix, Oxford, UK) around the left renal
artery, which was accessed via a mini-laparotomy. The
flowprobe was connected to a T106 Transonic flow
meter (Transonics Systems, Ithaca, NY, USA) with in-
built calibrations, which was in turn connected to a
laptop containing powerlab software (ADInstruments,m+HF CPB CPB + HF ANOVA
= 6) (n = 8) (n = 6) P value
.2 (4.1) 56.4 (1.4) 72.9 (1.8) 0.001
.2 (5.9) 132.3 (7.0) 136.8 (5.6) 0.937
(0.22) 1.9 (0.40) 1.6 (0.30) 0.209
.5 (17.1) 116.4 (12.9) 122.7 (19.9) 0.791
(0.2) 2.1 (0.2) 1.6 (0.3) 0.327
.3 (2.5) 1.5 (0.8) 12.8 (3.4) <0.001
.7 (1.7) 82.4 (2.4) 71.7 (1.5) 0.062
00 to 5,000) 5,500 (5,000 to 6,000) 5,125 (3,500 to 5,500) 0.230
.1 (0.2) 8.9 (0.3) 9.2 (0.6) 0.064
0 to 0) 5.5 (0.5 to 15) 13.0 (10.0 to 17.0) 0.007
.9 (2.0) 41.7 (6.7) 53.8 (1.6) 0.01
76 to 416) 454 (400 to 488) 450 (374 to 476) 0.355
(0.03) 1.1 (0.07) 1.0 (0.05) 0.148
e). Pairwise comparisons derived from analysis of variance (ANOVA) for weight
−1.2), P = 0.016; Sham–CPB, 0.6 kg 95% CI = −5.8 to 6.9), P = 1.0; Sham–CPB +
25.1 to −7.7), P <0.001. Pairwise comparisons derived from ANOVA for
.9), P = 0.959; Sham–CPB, −11.9 mg (95% CI = −20.9 to −2.9), P = 0.012;
% CI = −12.3 to 7.7), P = 0.651. CPB, cardiopulmonary bypass; HF, high-fat diet;
Figure 1 (See legend on next page.)
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Figure 1 Anaesthesia and cardiopulmonary bypass. (A) Mean arterial blood pressure (MABP). (B) Central venous oxygen saturation (ScVO2).
(C) Global oxygen delivery (DO2) during cardiopulmonary bypass (CPB). (D) DO2 during CPB adjusted for body mass. (E) Periprocedural
haemoglobin (Hb) concentrations. (F) Periprocedural partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ratios. (G) Lung
compliance. (H) Work of breathing. Key for line diagrams: black solid, Sham; black hatched, Sham + HF; grey solid, CPB; grey hatched, CPB + HF.
Values represent mean (standard error of the mean), at least n = 6 per group. For graphs, pooled estimates for pairwise comparisons derived from
analysis of variance for repeated measures and adjusted for mean baseline. Estimates for baseline values were as follows: MABP, 79 mmHg; ScVO2,
83.4%; DO2 556 ml/minute; Hb, 9.1 g/dl; PaO2/FiO2 386 mmHg, compliance 43.2 J/l. MABP: Sham–Sham +HF, 1.5 mmHg (95% CI = −5.5 to 8.5), P = 1.0;
Sham–CPB, 12.6 mmHg (95% CI = 6.8 to 18.5), P <0.001; Sham–CPB + HF, 7.9 mmHg (95% CI = 0.3 to 15.4), P = 0.037; CPB–CPB + HF, −4.7 mmHg
(95% CI = −3.3 to 12.8), P = 0.654; test for overall treatment effect for MABP, P <0.001; test for Time* Group interaction, P <0.001. ScVO2: Sham–
Sham + HF, 3.3% (95% CI = −4.8 to 11.4), P = 1.0; Sham–CPB, 20.4% (95% CI = 11.7 to 29.0), P <0.001; Sham–CPB + HF, 15.2% (95% CI = 5.3 to
25.2), P = 0.002; CPB–CPB + HF, −5.1% (95% CI = −16.5 to 6.2), P = 1.0; test for overall treatment effect for ScVO2, P <0.001; test for Time* Group
interaction, P = 0.134. Oxygen delivery: CPB–CPB + HF, 0.69 ml/minute (95% CI = −199 to 201), P = 0.994; test for Time* Group interaction, P =
0.184. Oxygen delivery index: CPB–CPB + HF, 0.95 ml/kg/minute (95% CI, −4.4 to 2.5), P = 0.534; test for Time* Group interaction, P = 0.505. Hb:
test for overall treatment effect, P = 0.351; test for Time* Group interaction, P = 0.653. PaO2/FiO2: test for overall treatment effect, P = 0.393; test
for Time* Group interaction, P = 0.486. Compliance: test for overall treatment effect, P = 0.381; test for Time* Group interaction, P = 0.098. Work
of breathing: test for overall treatment effect, P = 0.295; test for Time* Group interaction, P = 0.086. CI, confidence interval; HF, high-fat diet.
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in litres per minute. To avoid vasoconstriction (as a re-
sult of manipulation) confounding our results, a 10-
minute rest or nonmanipulation period was provided
prior to baseline measurements. This was followed by a 5-
minute period of baseline flow measurements and then
infusion of acetylcholine or sodium nitroprusside for 5 mi-
nutes during which flow was continuously monitored.
The mean flow during the time period was calculated and
flow measurements were performed in triplicate both with
and without acetylcholine/sodium nitroprusside. Endothe-
lial dysfunction was determined by the change in renal
blood flow in response to an acetylcholine infusion (0.1 to
10 μg/kg/minute) administered via a 14G peripheral ven-
ous cannula (BD Venflon, Becton Dickinson, Oxford, UK)
inserted into the suprarenal abdominal aorta. Sodium ni-
troprusside (0.1 to 10 nmol/kg/minute) was used to con-
trol for endothelium-independent relaxation. Renal
cortical and medullary nucleotide levels were measured
using reverse-phase high-performance liquid chromatog-
raphy as described previously [17,18].
Renal tissue
Using formalin-fixed, paraffin-embedded, or snap-frozen
5 μm transverse renal sections, immunocytochemistry
using the Vector avidin–biotin complex method (Vector
Laboratories, Peterborough, UK) or immunofluorescence
was performed for ET-1 (Acris, Herford, Germany), a
marker of inflammation, and endothelial nitric oxide syn-
thase (Santa Cruz Biotechnology, Heidelberg, Germany), a
marker of endothelial homeostasis, inflammatory cells,
(MAC-387; Abcam, Cambridge, UK), and cell prolifera-
tion (proliferating cell nuclear antigen; Sigma, St Louis,
MO, USA). Cell staining density was determined by
counting the number of cells in a 0.125 mm2 area. Vascu-
lar endothelium was identified by percent staining of im-
munocytochemistry for biotinylated dolichos biflorus
agglutinin lectin (Vector Laboratories). Levels of apoptosiswere determined by western blotting for cleaved caspase-3
(Calbiochem, UK), as were levels of expression of markers
of renal inflammation, and cell survival ET-1 (Acris), p65
nuclear factor-kappa B (NF-κB; Cell Signaling Technol-
ogy, Beverly, MA, USA), inducible nitric oxide synthase
(iNOS; Thermo Fisher Scientific, Waltham, MA, USA),
vascular endothelial growth factor (VEGF; Calbiochem),
and B-cell lymphoma-2 (Bcl2; Cell Signaling Technol-
ogy), Akt, phospho-Akt (Ser473) and p70S6K (all Cell
Signaling Technology), and hypoxia inducible factor
(HIF)-1 alpha (Sigma), as described previously [17,18].
Power of the study and statistical analysis
Creatinine clearance, which we have previously validated
as an index of GFR in this model (correlation coefficient
0.74 to 0.78) [15,17], was the primary endpoint. We calcu-
lated that a study with 24 animals (six per group) would
have a 90% power to detect a large effect size of 0.7 stand-
ard deviations, equivalent to a difference of 16.5 ml/minute
in creatinine clearance between groups assuming a within-
group standard deviation of 23.5. Extra animal experiments
(n = 4) were added to some groups to complete endothelial
function testing in at least four animals per group. Data are
expressed throughout as mean (standard error of the
mean) or median (interquartile ranges) and treatment dif-
ferences are reported as mean difference (95% confidence
interval). Differences between groups were calculated using
analysis of variance with adjustment for baseline differ-
ences for repeated measures. Non-normally distributed
data were log transformed with effect estimates reverse
transformed to express effect size and CIs on a linear scale.
P <0.05 was considered statistically significant. All analyses
were carried out using SPSS 14.0 (SPSS Inc., Chicago, IL,
USA).
Results
Anaesthesia, recovery and reassessment were completed
in all animals. Baseline characteristics are presented in
Figure 2 (See legend on next page.)
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Figure 2 Biochemical Markers of AKI. (A) Creatinine clearance, an index of GFR, as per Figure 1A. (B) IL-6, a serum biomarker of AKI, (C) Serum
Creatinine, (D) IUrinary Neutrophil Gelatinase-Associated Lipocalcin (NGAL), a urinary AKI biomarker . Values represent mean (SEM) at least n = 6
per group. (E) Immunofluorescence for tubular Endothelin-1 expression at 24 Hours post Intervention, quantified by Western Blotting and
densitometry as described. Values represent mean (SEM) at least n = 6 per group. *p <0.05 versus sham, †p <0.05 versus Sham+HF, ‡p <0.05
versus CPB. For graphs pooled estimates for pairwise comparisons derived from Analysis of Covariance with adjustment for baseline Creatinine
Clearance estimated at 114 ml/min, serum creatinine 135 µmol/L, serum IL-6 estimated at 18.6 pg/ml, urinary NGAL creatinine ratio estimated at
3.69 ng/µmol, were as follows: Creatinine Clearance; Post CPB Intervention: Sham- Sham + HF, 25.9 ml/min (95% CI -19.4 to 71.1), p = 0.249,
Sham-CPB 50.2 ml/min (95% CI 5.9 to 94.4), p = 0.028, Sham-CPB + HF 52.9, (95% CI 7.1 to 98.6), p = 0.026. Test for overall treatment effect
p = 0.079. Day 1 Post intervention: Sham-Sham+HF, -14.8 ml/min (95% CI 56.7 to 27.1), p = 472, Sham-CPB 42.7 ml/min (95% CI 3.8 to 81.5),
p = 0.033, Sham-CPB + HF -22.6 ml/min, (95% CI -65.0 to 19.7), p = 0.280, CPB-CPB + HF -65.3 ml/min (95% CI -106.9 to -23.7) p = 0.004. Test for
overall treatment effect p <0.001. Serum Creatinine; Post CPB Intervention: Sham-Sham + HF, -9.5 µmol/L (95% CI -17.2 to -1.7), p = 0.019,
Sham-CPB -9.9 µmol/L (95% CI -17.5 to -2.4), p = 0.012, Sham-CPB + HF -11.9 µmol/L, (95% CI -20.1 to -3.9), p = 0.006. Test for overall treatment
effect p = 0.017. Day 1 Post intervention: Test for overall treatment effect p = 0.788. Serum IL-6; Post Intervention: Sham-Sham + HF -1.5 pg/ml
(95% CI -9.3 to 6.4), p = 0.701, Sham-CPB -11.3 (95% CI -19.6 to -3.2), p = 0.009, Sham-CPB + HF -3.5, (95% CI -12.1 to 5.0), p = 0.399. Test for
overall treatment effect p = 0.039. Day 1 Post Intervention: Sham-Sham + HF, -1.0 pg/ml (95% CI -3.7 to 1.7), p = 0.433, Sham-CPB -5.9 pg/ml
(95% CI -8.7 to -3.2), p <0.001, Sham-CPB + HF -2.1 pg/ml, (95% CI -4.9 to 0.83), p = 0.153. Test for overall treatment effect p = 0.001. Urinary
NGAL/ Creatinine Ratio; Post Intervention: Sham-Sham + HF, 0.11 (95% CI 0.04 to 0.37), p = 0.001, Sham-CPB 0.16 (95% CI 0.04 to 0.66),
p = 0.014, Sham-CPB + HF 0.09, (95% CI 0.02 to 0.40). Test for overall treatment effect p = 0.004. Day 1 Post Intervention: Test for overall
treatment effect p = 0.601.
Sleeman et al. Critical Care 2013, 17:R262 Page 7 of 15
http://ccforum.com/content/17/5/R262Table 1. Pigs fed a high-fat diet were significantly heavier
compared with those fed a normal chow diet. Weight
gain was attributed in significant part to the accumula-
tion of adipose tissue on the trunk (>2 cm), neck
(>3 cm) and surrounding the viscera, which was not evi-
dent in pigs fed a normal chow diet. A high-fat diet also
resulted in significant hyperlipidaemia (Table 1). There
was no difference between the groups for baseline cre-
atinine clearance. During the 2.5-hour intervention time
period, CPB resulted in lower perfusion pressures and
lower central venous oxygen saturation values compared
with Sham pigs, with no difference between CPB and
CPB +HF groups, or between Sham and Sham +HF
groups for these measures (Figure 1A,B). There was no
significant difference between CPB and CPB +HF pigs
in terms of global oxygen delivery (Figure 1C) or oxygen
delivery indexed to body mass during CPB (Figure 1D).
Pigs undergoing bypass required significantly higher
doses of vasopressor compared with pigs undergoing
Sham procedures (Table 1); however, doses administered
to CPB and CPB +HF groups were not significantly dif-
ferent. There were no differences between the groups
with respect to periprocedural haemoglobin concentra-
tions or gas exchange (PaO2/FiO2 ratio) (Figure 1E,F).
Lung compliance was higher in the CPB + HF group at
baseline, but no treatment effect on compliance was de-
tected between the groups post intervention or for work
of breathing (Figure 1G,H).
Sham operated pigs fed a high-fat diet
Sham+HF pigs demonstrated similar creatinine clearance
over the 24-hour follow-up period compared with non-HF
Sham pigs (Figure 2A). Serum creatinine levels were also
similar at 24 hours post intervention (Figure 2B).Measures of inflammation in serum IL-6 were not in-
creased by a high-fat diet (Figure 2C) although specific
markers of renal inflammation, urine NGAL levels and
intrarenal ET-1 expression, were significantly elevated
post intervention (Figure 2D,E). NGAL levels were signifi-
cantly elevated immediately post intervention, but inter-
group differences were no longer significant at 24 hours.
Tissue analysis at 24 hours showed ET-1 co-localised to
pseudo-dilated renal tubules. We have shown previously
that this is indicative of epithelial cell stress [17]. The
high-fat diet resulted in inflammation that was associated
with marked reductions in endothelial nitric oxide syn-
thase expression and significant increases in micro-
vascular staining (Dolichos biflorus agglutinin lectin)
density (Figure 3A,B). Renal artery flows and endothe-
lial responsiveness to acetylcholine were unchanged
from non-HF Sham pigs at 24 hours although there
were differences in regional purine nucleotide levels;
medullary ATP levels were increased and levels of ad-
enosine were reduced (Figure 3C,D,E). We have shown
previously that these changes are indicative of alterations
in regional perfusion [18,19]. In high-fat diet pigs, inflam-
mation was associated with high rates of tubular epithelial
proliferation (Figure 4A) and increased p65 NF-κB expres-
sion (Figure 4B), as well as increased expression of the
proteins encoded by several NF-κB-dependent genes:
iNOS, VEGF and Bcl2 (Figure 4C,D,E). The high-fat diet
did not alter pro-survival pAkt/p70S6K/HIF-1α signalling
(Figure 5A,B,C) or levels of cleaved caspase 3, a marker of
apoptosis relative to non-HF Sham pigs (Figure 5D).
Cardiopulmonary bypass in pigs fed a normal diet
CPB in pigs fed a normal diet resulted in AKI charac-
terised by sustained reductions in creatinine clearance
Figure 3 (See legend on next page.)
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Figure 3 Endothelial homeostasis (A) Immunofluorescence for glomerular endothelial nitric oxide synthase (eNOS) at 24 hours post
intervention and immunocytochemistry (ICC) for dolichos biflorus agglutinin (DBA) lectin. eNOS staining was almost completely absent in
high-fat diet (HF) swine. Glomerular eNOS staining in cardiopulmonary bypass (CPB) swine was reduced and this was associated with endothelial
dysfunction and reduced glomerular filtration rate (GFR). DBA lectin staining was reduced in CPB pigs indicative of glycocalyceal loss but was
preserved in CPB + HF pigs indicating maintenance of endothelial homeostasis. There was increased microvascular staining density in HF pigs that
may underlie the preservation of renal blood flow observed in CPB + HF pigs. (B) Quantification of ICC for DBA lectin staining expressed as
percentage staining at 24 hours post injury. (C) Renal blood flow/kilogram body weight (RBF) measured on a single renal artery via laparotomy.
NO dependent vascular reactivity was determined by the change in renal blood flow in response to an infusion of acetylcholine (RBF post Ach).
(D) ATP and (E) adenosine levels, expressed as ratios in the renal cortex and medulla at 24 hours post intervention. Values represent mean
(standard error of the mean) of at least n = 4 per group. *P <0.05 versus sham, †P <0.05 versus Sham + HF, ‡P <0.05 versus CPB.
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24-hour follow-up period (Figure 2A,C). These changes
were not reflected in altered serum creatinine values at
24 hours (Figure 2B). CPB also resulted in significant in-
creases in markers of renal inflammation, urinary NGAL
at 1.5 hours and intrarenal ET-1 at 24 hours, compared
with Sham operated non-HF controls (Figure 2D,E).
Levels of ET-1 expression and serum IL-6 were signifi-
cantly greater in these pigs relative to all other experi-
mental groups, but urine NGAL levels were found to be
lower than those in the high-fat groups. CPB resulted in
significant loss of endothelial nitric oxide synthase and
vascular endothelial staining density (Figure 3A,B). CPB
also resulted in endothelial dysfunction, as indicated by
an attenuation of renal endothelial responsiveness to
acetylcholine, depletion of ATP and increased adenosine
in the renal cortex and reciprocal increased ATP and re-
duced adenosine in the renal medulla (Figure 3C,D,E).
CPB was associated with increased p65 NF-κB and iNOS
expression and increased tubular proliferation rates
(Figure 4A,D,C). Unlike Sham + HF pigs, VEGF was not
increased (Figure 4E), and this is perhaps attributable to
the more severe inflammation evident in this group.
Levels of the apoptosis marker cleaved caspase 3 were
increased relative to other groups despite a significant
increase in pro-survival pAkt/p70S6K/HIF-1α/Bcl 2 sig-
nalling (Figure 5A,B,C,D).
Cardiopulmonary bypass in pigs fed a high-fat diet
In CPB +HF swine, creatinine clearance was reduced
immediately post CPB; however, unlike in CPB-only
pigs, this was not associated with increases in serum IL-
6 (Figure 2A,C) and by 24 hours creatinine clearance
had recovered and was similar to those in both Sham
groups. ET-1 levels were reduced relative to that ob-
served in CPB-only pigs (Figure 2E). Renal blood flow
was increased at 24 hours, in association with preserva-
tion of microvascular density relative to Sham +HF pigs,
and endothelial homeostasis was preserved as deter-
mined by renal blood flows and endothelial responsive-
ness to acetylcholine (Figure 3). p65 NF-κB expression
was increased relative to Sham-only pigs, as was expres-
sion of iNOS, and the rate of tubular epithelial cellproliferation (Figure 4A,B,C). VEGF and Bcl2 expression
were reduced (Figure 4D,E), however, as was pro-survival
pAKt/p70S6K/HIF-1α signalling (Figure 5A,B,C). Levels
of the apoptosis marker cleaved caspase 3 were similar to
those in Sham groups (Figure 5D).
Discussion
A 12-week high-fat diet resulted in significant obesity
and hyperlipidaemia in swine. This promoted inflamma-
tory cell signalling, vascular endothelial homeostasis,
and epithelial cell survival in swine kidneys, preserved
renal blood flow and GFR, and prevented CPB-mediated
injury.
This study has several strengths, in particular the abil-
ity to evaluate functional, biochemical and histological
changes in kidneys in response to clinical stimuli such as
CPB, or obesity, in a large animal recovery model of AKI
where the physiology has significant homology to that
observed in humans [15-18]. An important finding from
this study is the clear association between acutely ele-
vated serum IL-6 levels, a candidate biomarker for AKI
currently being evaluated in clinical studies [20], and
persistent reductions in GFR at 24 hours that are associ-
ated with ongoing inflammation and hypoxia. In contrast
to IL-6, urinary NGAL was increased by a HF diet and
did not discriminate between pigs that did or did not de-
velop sustained reductions in GFR. This is consistent
with false positives of this AKI biomarker in clinical
studies in patients with pre-existing inflammatory states
such as chronic kidney disease [21]. The acute (within
1.5 hours) elevation in IL-6 also highlights the limita-
tions of existing clinical definitions of AKI that are based
on peak serum creatinine levels detected up to 48 hours
post injury [1,2]. Our model does not show significant
rises in serum creatinine at 24 hours post CPB, indicat-
ing a modest degree of injury. This contrasts with
models of AKI in swine that involve periods of arterial
occlusion and reperfusion (ischaemia and reperfusion),
which can demonstrate acute rises in serum creatinine
within hours [22,23]. This picture is not typical of post-
cardiac surgery AKI, however; clinical studies indicate
that serum creatinine does not rise for up to 48 hours
post surgery in patients with AKI [24]. Warm ischaemia
Figure 4 (See legend on next page.)
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Figure 4 Proliferation and p60 NF-κB signalling. (A) Proliferating tubular epithelial cell (proliferating cell nuclear antigen-positive) count in the
inner cortex at 24 hours post intervention. (B) p60 nuclear factor-kappa B (NF-κB) expression, and expression of proteins encoded by the NF-κB-
dependent genes: (C) Inducible nitric oxide synthase (iNOS). (D) B-cell lymphoma protein 2 (Bcl2). (E) Vascular endothelial growth factor (VEGF).
VEGF expression was increased in Sham + HF pigs, was also associated with increased microvascular density. Values derived from densitometry of
western blots and expressed as a ratio to β-actin or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Representative blots are shown. Values
represent mean (standard error of the mean) of at least n = 4 per group. *P <0.05 versus sham, †P <0.05 versus Sham + HF, ‡P <0.05 versus cardio-
pulmonary bypass (CPB). HF, high-fat diet.
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vere renal injury, with measured mean creatinine clear-
ance of 7 ml/minute 4 hours following reperfusion in
one study [22]. This is not consistent with measured cre-
atinine clearances that we have documented after car-
diac surgery [16]. Together, these studies underpin the
value of translational models that can reflect different
clinical scenarios. In the case of post-CPB AKI, our
work indicates an inflammatory pathogenesis as op-
posed to ischaemia and reperfusion caused by periods
of arterial occlusion where tubular necrosis is more
marked [22,23].
Epidemiological studies have speculated as to the
causal pathway between obesity and improved clinical
outcomes in the critically ill, with some reports suggest-
ing that these observations may be attributed to attenu-
ation of the inflammatory response [12,13]. In contrast,
our results indicate that renal protection was conferred
by increased renal inflammation attributable to an obe-
sogenic high-fat diet. This apparent paradox merits a
careful consideration of the limitations of the current
study. AKI in young healthy female swine may not re-
flect the multifactorial AKI observed in older cardiac
surgery patients. For example, atherosclerosis, a com-
mon finding in the older cardiac patient, has been
shown to alter inflammation and repair mechanisms in
swine models of renal ischaemia and reperfusion [22,23].
Weight gain in young swine may also be attributed to
increase in muscle as well as adipose tissue, although
adiposity was marked in these animals. Serum lipid
levels were higher than those commonly recorded in
humans. The principal limitation of this study is that we
cannot differentiate the effects of obesity as distinct from
the effects of hyperlipidaemia on outcomes. Previous
work has demonstrated that hypercholesterolaemic
homozygous apolipoprotein-E-deficient mice fed a high-
fat diet are resistant to ischaemic AKI [25] in the ab-
sence of obesity. Similarly, pigs fed a high-fat diet that
develop hyperlipidaemia in the absence of significant
weight gain are protected against myocardial ischaemia
reperfusion injury [26]. In that study, similar to our own
findings, the protective effects of high-fat feeding and
hyperlipidaemia in porcine myocardium were attributed
to preserved endothelial homeostasis and increased
microvascular density in the presence of inflammationand oxidative stress [26]. This suggests that it is the
chronic renal inflammation consequent to hyperlipid-
aemia which protects against post-CPB AKI. Obesity
may in fact represent an epiphenomenon; a bystander
also attributable to high-fat feeding that is more readily
measureable in epidemiological analyses, and this is
reflected by the assessment of important additional
confounders such as lipoprotein levels in more recent
observational analyses of the obesity paradox [27]. We
emphasise that our study, however, cannot discount an
additional and potentially important neurohormonal and
metabolic role for adipose tissue in our observations.
This merits further study.
A significant finding in the current study was the asso-
ciation between intrarenal inflammation and both pro-
survival and pro-apoptotic signalling. Previous studies
have shown that the changes in renal vascular and tubu-
lar homeostasis that we have observed in response to a
high-fat diet in swine are dependent on proinflammatory
redox signalling [28,29]. A key signalling node in this re-
spect is NF-κB [29-31], a redox-sensitive proinflamma-
tory transcription factor the expression of which was
increased by a high-fat diet in the current study, as was
the expression of proteins encoded by several NF-κB-
dependent genes, iNOS, VEGF and Bcl2 [32]. In con-
trast, in the CPB pigs fed a normal diet, acute increases
in NF-κB as well as iNOS and Bcl2 expression were as-
sociated with loss of endothelial homeostasis as well as
increases in cleaved caspase 3, a marker of apoptosis.
This was associated with more severe inflammation, as
determined by ET-1 expression and serum IL-6 levels,
and ATP depletion observed following CPB. These are
potent drivers of tubular epithelial apoptosis and endo-
thelial injury [33-35] that may modify NF-κB signalling,
as evinced in this case by the suppression of VEGF
[36], and may promote cell death. It is also noteworthy
that apoptosis in CPB pigs fed a normal diet was associ-
ated with activation of the key pro-survival node AKt.
As with NF-κB it may be that the severity of the inflam-
mation and ATP depletion caused by the CPB injury
exceeded the protective effects of Akt signalling. In
complete contrast, the preconditioning against AKI by
a high-fat diet was independent of the phosphorylation
of Akt, which is recognised as an important signalling
node in acute ischaemic preconditioning [37]. Akt
Figure 5 (See legend on next page.)
Sleeman et al. Critical Care 2013, 17:R262 Page 12 of 15
http://ccforum.com/content/17/5/R262
(See figure on previous page.)
Figure 5 Survival signalling and apoptosis. (A) Pro-survival signalling; expressed as pAKt:Akt ratio and levels of downstream effectors.
(B) Hypoxia inducible factor (HIF)-1 alpha. (C) p70S6K, a signalling protein in the Akt/mTOR pathway. (D) Apoptotic signalling as indicated by
cleaved caspase 3 (CC3) levels, with values derived from densitometry of western blots and expressed as a ratio to β actin or glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). Representative blots are shown. Values represent mean (standard error of the mean) of at least n = 4
per group. *P <0.05 versus sham, †P <0.05 versus Sham + HF, ‡P <0.05 versus CPB.
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relative to other groups, as was the expression of proteins
in several related pro-survival signalling pathways includ-
ing p70S6K (mTOR), Bcl2 (anti-apoptotic) and HIF-1α
(angiogenesis). This is not entirely counterintuitive; de-
creased mammalian target of rapamycin signalling in-
creases autophagy, an important protective mechanism in
AKI [38]. Moreover, reduced mammalian target of rapa-
mycin signalling alongside reduced HIF-1α expression
promotes the polarisation of macrophages from the
classically activated (M1) proinflammatory phenotype
(thereby reducing IL-6 release) towards the alternatively
activated reparative (M2) phenotype [39] that can pro-
mote renal recovery.
Of immediate translational relevance was our finding
that inflammation was associated with both pro-survival
and pro-apoptotic processes. More specifically, we ob-
served pleiotropic effects of NF-κB signalling in the
current study that have also been demonstrated in other
models of renal vascular endothelial and tubular epithe-
lial injury [40,41]. This suggests that inflammatory redox
signalling can have a protective role in AKI, either as a
form of preconditioning or perhaps as an important
process in cell repair. Consequently, blanket inhibition
of inflammation or oxidative stress may not confer an
overall benefit to patients at risk of AKI, and this is sup-
ported by the failure of anti-inflammatory interventions
such as statins, corticosteroids, and antioxidants to re-
duce post-cardiac surgery AKI severity in randomised
trials [42,43]. Here we speculate that it is perhaps the
dysregulation of inflammatory responses, typical of risk
factors such as diabetes and chronic kidney disease
[44,45], or prolonged CPB [3] that predisposes to clinical
AKI.
Conclusion
Our study demonstrates that high-fat feeding in swine
results in obesity, hyperlipidaemia and renal inflamma-
tion. This protects against post-CPB AKI. Moreover,
proinflammatory signalling was associated with both
renal injury and protection. These observations demon-
strate the complexity and redundancy of proinflamma-
tory and pro-survival signalling pathways in the setting
of post-CPB AKI, cast light on the failure of historical
interventions to improve outcomes in patients at risk,
and highlight the value of complex large animal recovery
models in translational research.Key messages
 Observational analyses describe an association
between obesity and improved clinical outcomes in
the critically ill and those undergoing major surgery;
a phenomenon that has been labelled the Obesity
Paradox.
 No mechanism has been put forward to explain the
Obesity Paradox, and the validity of these
observations has been questioned.
 In this study we document that a high-fat diet,
which results in hyperlipidaemia and obesity,
protects against post-CPB AKI in swine by promoting
renal inflammation, cellular proliferation and
vascular homeostasis.
 This suggests that pre-existing inflammation may
pre-condition organs against ischaemia reperfusion
injury and provides a hypothetical basis for the
Obesity Paradox observed in clinical studies.
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